Group 1 - The third meeting of the board of directors of Xuchang Kaipu Testing Research Institute Co., Ltd. was held on August 8, 2025, with all five directors present, confirming the legality and validity of the meeting [1] - The board approved the profit distribution plan for the first half of 2025, proposing a cash dividend of 3 yuan per 10 shares, totaling 31,200,000 yuan (including tax) based on a total share capital of 104,000,000 shares as of June 30, 2025 [2] - The board has been authorized by the annual general meeting to formulate and implement the mid-term dividend plan for 2025, and this proposal does not require further approval from the shareholders' meeting [3] Group 2 - The company plans to adjust its organizational structure and amend its articles of association, with the management authorized to handle the necessary registration and filing procedures [3][4] - Several proposals regarding the independent director system, external guarantee management, external investment management, related party transaction management, and fundraising management were approved by the board and will be submitted for shareholder meeting approval [5]

Group 1 - The third meeting of the supervisory board of Xuchang Kaipu Testing Research Institute Co., Ltd. was held on August 8, 2025, and was deemed legally valid [1] - The supervisory board approved the 2025 semi-annual report, confirming that the report accurately reflects the company's actual situation without any false records or omissions [1][2] - The supervisory board agreed to the 2025 semi-annual profit distribution plan, stating it aligns with the company's actual conditions and relevant regulations, promoting sustainable development [2] Group 2 - The supervisory board approved the adjustment of the organizational structure and the revision of the company's articles of association, confirming compliance with relevant laws and regulations [3] - The decision regarding the organizational structure adjustment will be submitted to the shareholders' meeting for further approval [3]

证券代码：003008 证券简称：开普检测 公告编号：2025-035 （http://wltp.cninfo.com.cn）向全体股东提供网络形式的投票平台，公司股东可以 在网络投票时间内通过上述系统行使表决权。公司股东只能选择现场投票和网络 投票中的一种表决方式，如果同一表决权出现重复投票表决的，以第一次有效投 票表决结果为准。 许昌开普检测研究院股份有限公司 关于召开公司 2025 年第一次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 许昌开普检测研究院股份有限公司（以下简称"公司"）第三届董事会第十 四次会议审议通过了《关于提请召开许昌开普检测研究院股份有限公司 2025 年 第一次临时股东大会的议案》，决定于 2025 年 8 月 26 日（星期二）下午 14:00 召开公司 2025 年第一次临时股东大会。现就本次股东大会的相关事项通知如下： 一、召开会议的基本情况 《关于提请召开许昌开普检测研究院股份有限公司 2025 年第一次临时股东大会 的议案》，本次股东大会会议的召开符合有关法律、行政法规、部门规章、规范 性文件、深圳 ...

Core Viewpoint - The financial report of Xuchang KETOP Testing Research Institute Co., Ltd. for the first half of 2025 indicates a decrease in total assets and liabilities compared to the beginning of the year, with a notable change in cash flow and net profit. Financial Summary Assets - Total assets at the end of the period amount to ¥1,111,128,904.91, down from ¥1,156,643,926.36 at the beginning of the year, reflecting a decrease of approximately 3.9% [2][3] - Current assets total ¥710,038,426.38, a decrease from ¥735,393,864.16, representing a decline of about 3.4% [2][3] - Non-current assets amount to ¥401,090,478.53, down from ¥421,250,062.20, indicating a decrease of approximately 4.8% [3] Liabilities - Total liabilities are reported at ¥44,724,177.80, down from ¥79,029,008.83, showing a significant reduction of about 43.5% [3][5] - Current liabilities total ¥43,430,381.70, a decrease from ¥77,249,322.98, reflecting a decline of approximately 43.7% [3][5] - Non-current liabilities amount to ¥1,293,796.10, down from ¥1,779,685.85, indicating a decrease of about 27.3% [3] Equity - Total equity stands at ¥1,066,404,727.11, down from ¥1,077,614,917.53, reflecting a decrease of approximately 1.0% [3] - The company's capital reserve remains unchanged at ¥615,502,846.67 [3][5] Revenue and Profit - Total operating revenue for the first half of 2025 is ¥111,331,192.32, an increase from ¥107,850,944.77 in the same period of 2024, representing a growth of about 4.5% [5] - Total operating costs amount to ¥65,588,389.23, up from ¥59,896,286.17, indicating an increase of approximately 9.2% [5] - Net profit for the period is reported at ¥40,789,809.58, compared to ¥39,321,831.94 in the previous year, showing an increase of about 3.7% [6] Cash Flow - Net cash flow from operating activities is ¥51,322,215.95, compared to ¥49,969,659.85 in the previous year, reflecting an increase of approximately 2.7% [8] - Cash and cash equivalents at the end of the period total ¥89,566,273.34, down from ¥93,618,994.92 at the beginning of the year, indicating a decrease of about 4.0% [8]

Summary of Key Points Core Viewpoint - The document outlines the financial interactions between the listed company and its related parties, detailing non-operating fund occupations and other financial transactions, which are crucial for understanding the company's financial health and relationships with stakeholders [1]. Group 1: Non-Operating Fund Occupation - The document lists the non-operating fund occupations by the controlling shareholders and their affiliates, indicating the total amount of funds occupied and the nature of these occupations [1]. - It specifies that there are no significant amounts owed to or from controlling shareholders, as the company does not have a controlling shareholder [1]. Group 2: Related Party Transactions - The document details the amounts related to accounts receivable and payable with other related parties, highlighting significant figures such as 144,453.92 for accounts receivable and 918,404.00 for prepaid accounts [1]. - It emphasizes that the total amount of related party transactions is 1,062,857.92, which is essential for assessing the company's liquidity and operational efficiency [1]. Group 3: Financial Reporting and Governance - The document is prepared by the Xuchang Kaipu Testing Research Institute Co., Ltd., indicating a formal governance structure in place for financial reporting [1]. - The legal representative and accounting personnel are identified, ensuring accountability and transparency in financial disclosures [1].

Group 1 - The company held the 14th meeting of the 3rd Board of Directors and the 12th meeting of the 3rd Supervisory Board on August 8, 2025, to approve the proposal for organizational restructuring and amendments to the Articles of Association [1][2] - The amendments to the Articles of Association include changes to the rules governing shareholder meetings and board meetings, reflecting compliance with the new Company Law and relevant regulations [2][3] - The company aims to protect the legitimate rights and interests of shareholders, employees, and creditors while standardizing its organizational behavior [2][4] Group 2 - The company plans to revise specific articles in the Articles of Association, including the role of the chairman as the legal representative and the responsibilities associated with this position [4][5] - The company will ensure that all assets are divided into equal shares, and shareholders will be liable for the company's debts only to the extent of their subscribed shares [5][6] - The company emphasizes the importance of maintaining legal compliance and the rights of shareholders in its operational framework [6][7] Group 3 - The company’s operational mission is to act as a guardian of power grid safety, a creator of customer value, and a promoter of employee happiness, while adhering to social responsibilities [7][8] - The company aims to enhance profitability and provide returns to investors while maintaining a commitment to integrity and social responsibility [8][9] - The company’s shares will be issued based on principles of openness, fairness, and justice, ensuring equal rights for all shareholders of the same class [8][10]

一种基于继电保护定值 证券代码：003008 证券简称：开普检测 公告编 号：2025-037 许昌开普检测研究院股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、获得专利证书基本情况 许昌开普检测研究院股份有限公司（以下简称"公司"）于近日取得国家知 识产权局颁发的 1 项发明专利证书，具体情况如下： 专利 授权 序号 专利名称 专利号 证书 号 专利权人 申请日 公告日 二、对公司的影响 上述专利权的取得不会对公司生产经营产生重大影响，但有利于公司进一步 完善知识产权保护体系，发挥自主知识产权优势，并对公司的技术创新、产品创 新、市场及品牌影响力提升等方面产生积极的影响，提升公司的核心竞争力。 特此公告。 许昌开普检测研究院股份有限公司 测研究 许昌开普检 院股份有限 公司 成实现方法 上述发明专利的专利权期限为二十年，自申请日起算。 "一种基于继电保护定值类型的测试用例自动生成实现方法"发明专利成果 通过识别继电保护定值类型，确定测试用例中的必要参数实现测试用例的自动生 成。专利成果用于在继电保护产品的设计研发、型式检验、入网投运及定检维 ...

General Principles - The rules aim to improve the governance structure of Xuchang Kaipu Testing Research Institute Co., Ltd. and ensure the board of directors operates independently and effectively [1][2] - The board of directors is a permanent decision-making body responsible to the shareholders' meeting and must act within the authority granted by laws, regulations, and the company's articles of association [1][2] Meeting Convening and Notification - The board meetings can be proposed by shareholders holding more than 10% of voting rights, one-third of the directors, or the finance and audit committee [2] - Regular board meetings must be held at least twice a year, with notifications sent 10 days in advance for regular meetings and 3 days for temporary meetings [2][3] Meeting Procedures - A board meeting requires the presence of more than half of the directors to be valid [4] - Independent directors must attend personally and cannot delegate their voting rights unless they have reviewed the materials beforehand [4][5] Voting and Resolutions - Each director has one vote, and resolutions require a majority of the attending directors to pass [8][22] - In cases of conflicts of interest, relevant directors must abstain from voting, and decisions must be made by a majority of non-related directors [22][23] Meeting Records and Announcements - The board secretary is responsible for preparing and maintaining meeting documents, ensuring records are accurate and complete [27][29] - Resolutions must be reported to the Shenzhen Stock Exchange promptly after the meeting, including details of the voting results and any related transactions [32][34] Amendments and Effectiveness - The rules can be amended based on actual circumstances and must be approved by the shareholders' meeting [38][39] - The rules take effect upon approval by the shareholders' meeting [39]

Core Points - The company is established as a joint-stock company under the laws of the People's Republic of China, specifically the Company Law and Securities Law [1][2] - The registered capital of the company is RMB 104 million [2] - The company was approved for its initial public offering of 20 million shares on August 20, 2020, and listed on the Shenzhen Stock Exchange on September 23, 2020 [1][3] Company Structure - The company is named Xuchang KETOP Testing Research Institute Co., Ltd. and is located at 17 Shangde Road, Xuchang City, with a postal code of 461000 [2] - The company is a permanent joint-stock company, and its chairman serves as the legal representative [2][3] - The legal representative's civil activities conducted on behalf of the company will have legal consequences for the company [2] Business Objectives and Scope - The company's mission is to be a guardian of power grid safety, a creator of customer value, a facilitator of employee happiness, and a practitioner of social responsibility [3][4] - The business scope includes inspection and testing services, certification services, and power supply business, among others [4] Share Issuance and Capital Management - The company issues shares in the form of stocks, with each share having a par value of RMB 1 [5][6] - The total number of shares issued at the establishment of the company was 60 million, with a total of 10.4 million shares currently issued [5][6] - The company can increase its capital through various methods, including issuing shares to unspecified objects or existing shareholders [6][7] Shareholder Rights and Responsibilities - Shareholders have the right to receive dividends and participate in decision-making processes, including voting on significant company matters [10][11] - Shareholders holding more than 5% of voting shares must comply with specific regulations to protect the interests of the company and other shareholders [15][16] - The company must maintain a shareholder register to document ownership and rights [10][11] Governance and Meetings - The company holds annual and extraordinary shareholder meetings, with specific procedures for calling and conducting these meetings [19][20] - Decisions made at shareholder meetings require a majority or supermajority vote, depending on the nature of the resolution [78][80] - The company must ensure transparency and proper documentation of meeting proceedings, including voting results and shareholder inquiries [75][76]

General Principles - The purpose of the management measures for related party transactions is to standardize related party transactions of the company, protect the legitimate rights and interests of investors, especially minority shareholders, and ensure that contracts signed with related parties adhere to principles of fairness, justice, and openness [1][2] - Related transactions must comply with relevant laws, regulations, and the company's articles of association, and should not harm the rights of shareholders, particularly minority shareholders [2][3] Related Transactions - Related transactions refer to the transfer of resources or obligations between the company and its controlling companies with related parties, including but not limited to asset purchases or sales, external investments, financial assistance, guarantees, and management of assets and businesses [3][6] - Transactions must have commercial substance, fair pricing, and should not deviate from market prices or standards [3][6] Related Parties - Related parties include both legal entities and natural persons that have a special relationship with the company, such as those who control the company or hold more than 5% of its shares [7][8] - The company must maintain a list of related parties and their relationships, which should be reported to the board of directors [8] Procedures and Disclosure - Related party transactions require the avoidance of voting by related directors and shareholders during board and shareholder meetings [12][13] - The company must disclose related transactions in accordance with the regulations set forth, including obtaining independent financial advice when necessary [13][17] Approval and Limits - Transactions with amounts exceeding specified thresholds must be approved by independent directors and disclosed to shareholders [12][18] - The company can set limits for certain transactions, such as those below 300,000 RMB for legal entities or 30,000 RMB for natural persons, which can be approved by management [16][18] Daily Transactions - Daily related transactions must be disclosed and approved based on estimated annual amounts, with specific procedures for significant changes or renewals [14][15] - The company must report the actual execution of daily related transactions in its annual and semi-annual reports [14][15]